RECRUITING

Pounce™ Thrombectomy System Retrospective Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The PROWL registry is an open-label retrospective, multi-center, US study of the Surmodics™ Pounce™ Thrombectomy System for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.

Official Title

Pounce™ Thrombectomy System Retrospective Registry

Quick Facts

Study Start:2023-04-18
Study Completion:2025-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05868161

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Subject underwent an endovascular intervention where the Pounce Thrombectomy System was attempted
  2. * Subject is willing and able to provide informed consent prior to the collection of study data or a consent waiver is in place
  1. * Subject is under the age of 18 years

Contacts and Locations

Study Contact

Clinical Program Manager
CONTACT
1-866-787-6639
PROWLRegistry@surmodics.com

Principal Investigator

Sean Lyden, MD
PRINCIPAL_INVESTIGATOR
The Cleveland Clinic
Joseph Campbell, MD
PRINCIPAL_INVESTIGATOR
OhioHealth

Study Locations (Sites)

OSF St. Francis Medical Center
Peoria, Illinois, 61637
United States
Community Hospital
Munster, Indiana, 46321
United States
Baton Rouge General Medical Center
Baton Rouge, Louisiana, 70809
United States
Allina Health
Minneapolis, Minnesota, 55407
United States
Cleveland Clinic
Cleveland, Ohio, 44195
United States
Prisma Health Upstate
Greenville, South Carolina, 29601
United States
North Central Heart
Sioux Falls, South Dakota, 57108
United States
Vanderbilt University Medical Center
Nashville, Tennessee, 37212
United States
Ascension Seton
Austin, Texas, 78723
United States

Collaborators and Investigators

Sponsor: SurModics, Inc.

  • Sean Lyden, MD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic
  • Joseph Campbell, MD, PRINCIPAL_INVESTIGATOR, OhioHealth

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-18
Study Completion Date2025-07-31

Study Record Updates

Study Start Date2023-04-18
Study Completion Date2025-07-31

Terms related to this study

Additional Relevant MeSH Terms

  • Peripheral Arterial Disease
  • Acute Limb Ischemia